BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16138573)

  • 1. [Coreceptors CCR5 and CXCR4 expressions on peripheral blood T lymphocytes in HIV/AIDS patients].
    Zhao W; Wu YW; Liu W; Yao WH; Zhao H
    Zhonghua Nan Ke Xue; 2005 Aug; 11(8):574-6, 580. PubMed ID: 16138573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.
    Ostrowski MA; Justement SJ; Catanzaro A; Hallahan CA; Ehler LA; Mizell SB; Kumar PN; Mican JA; Chun TW; Fauci AS
    J Immunol; 1998 Sep; 161(6):3195-201. PubMed ID: 9743388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors.
    Kalinkovich A; Borkow G; Weisman Z; Tsimanis A; Stein M; Bentwich Z
    Clin Immunol; 2001 Jul; 100(1):107-17. PubMed ID: 11414751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of first, second, and third trimester placental factors on CD4, CCR5, and CXCR4 expression in human peripheral blood lymphocytes.
    Li LP; Kang JL; Xia W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 33(6):461-7. PubMed ID: 18599991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
    J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
    Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
    J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
    Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and coreceptor expression of T lymphocytes in HIV/AIDS patients of China.
    Shang H; Zhang Z; Jiang Y; Han X; Wang Y; Zhang M; Ye X; Liu Y; Diao Y; Dai D; Geng W
    J Clin Immunol; 2005 Jan; 25(1):68-72. PubMed ID: 15742159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro.
    Vassiliadou N; Tucker L; Anderson DJ
    J Immunol; 1999 Jun; 162(12):7510-8. PubMed ID: 10358206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency, activation, and coreceptor expression of lymphocytes in human immunodeficiency virus/hepatitis C virus co-infected patients in China.
    Shi W; Zhang Z; Zhang M; Liu J; Jiang Y; Wang Y; Jin X; Han X; Shang H
    Jpn J Infect Dis; 2009 Jul; 62(4):284-8. PubMed ID: 19628906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
    Joly M; Pinto JM
    Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor and chemokine receptor expression in HIV-infected T lymphocyte subsets.
    Miller Sanders C; Cruse JM; Lewis RE
    Exp Mol Pathol; 2010 Feb; 88(1):26-31. PubMed ID: 19769961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation.
    Berkowitz RD; Beckerman KP; Schall TJ; McCune JM
    J Immunol; 1998 Oct; 161(7):3702-10. PubMed ID: 9759895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human immunodeficiency virus (HIV) co-receptors expression in mononuclear leucocytes (ML) of HIV+ patients].
    Belmonte L; de Elizalde de Bracco MM; Ruibal-Ares B
    Medicina (B Aires); 2001; 61(5 Pt 2):670-2. PubMed ID: 12058586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with active tuberculosis have increased expression of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells.
    Juffermans NP; Speelman P; Verbon A; Veenstra J; Jie C; van Deventer SJ; van Der Poll T
    Clin Infect Dis; 2001 Feb; 32(4):650-2. PubMed ID: 11181132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide suppresses Up-regulation of human immunodeficiency virus coreceptors CXCR4 and CCR5 on CD4+ T cells in humans.
    Juffermans NP; Verbon A; Olszyna DP; van Deventer SJ; Speelman P; van Der Poll T
    J Infect Dis; 2000 May; 181(5):1813-6. PubMed ID: 10823791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE).
    Moss RB; Giermakowska WK; Diveley JP; Savary JR; Wallace MR; Maigetter RZ; Jensen FC; Carlo DJ
    J Hum Virol; 2000; 3(1):44-9. PubMed ID: 10774806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.